Peter Kolchinsky graduated from Harvard with a Ph.D. in virology in 2001. After graduation he got $4 Million from Vertex Pharma co-founder Rich Aldrich and started picking biotech stocks at RA Capital. In 2002 he broke even when the S&P 500 index lost 22%. By the end of 2003, the initial $4 Million investment became $13 Million. Boston-based RA Capital invests in companies with promising drugs and technologies.
| Fund Name: | RA Capital Management |
| Manager | Peter Kolchinsky |
| Portfolio Value | $7,153,595,000 |
| Change This QTR | +1.31% |
| No. | Security | Ticker | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|---|
| 1. | ASND | 5,865,338 | $978,221 | -1% | 13.67% | |
| 2. | TGTX | 8,685,471 | $451,818 | -2% | 6.31% | |
| 3. | NVAX | 3,788,564 | $422,463 | +217% | 5.9% | |
| 4. | NKTX | 5,605,129 | $344,547 | 4.81% | ||
| 5. | FMTX | 9,011,651 | $314,507 | 4.39% |
| Company | Symbol | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2021-03-02 | ||||
| 2021-02-19 | ||||
| 2021-02-16 | ||||
| 2021-02-16 |
